PHARMORE AS

3222 SANDEFJORD

Finances

Return on Equity

−4,42 %

Current Ratio

348,13

Debt-to-Equity Ratio

0,32

Key figures (NOK)	2022	2021	2020	2019
Revenue	344 000	853 000	883 000	796 000
Net Income	−1 386 000	16 473 000	9 043 000	18 730 000
Total Assets	41 366 000	52 861 000	46 976 000	43 744 000
Total Equity	31 327 000	42 680 000	32 207 000	29 164 000

Income (NOK)	2022	2021	2020	2019
Revenue	344 000	853 000	883 000	796 000
Expenditure	389 000	1 097 000	940 000	700 000
Operating Profit	−45 000	−245 000	−57 000	96 000
Financial Income	933 000	17 404 000	9 645 000	19 828 000
Financial Costs	2 271 000	706 000	560 000	1 201 000
Financial Balance	−1 338 000	16 698 000	9 085 000	18 627 000
Earnings Before Tax	−1 382 000	16 454 000	9 028 000	18 723 000
Tax	4 000	−19 000	−15 000	−7 000
Net Income	−1 386 000	16 473 000	9 043 000	18 730 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	27 441 000	27 758 000	26 541 000	26 564 000
Total Current Assets	13 925 000	25 102 000	20 435 000	17 180 000
Total Assets	41 366 000	52 861 000	46 976 000	43 744 000
Total Retained Equity	30 799 000	32 185 000	31 712 000	28 669 000
Total Equity	31 327 000	42 680 000	32 207 000	29 164 000
Total Long-Term Debt	10 000 000	10 000 000	8 000 000	8 000 000
Total Current Debt	40 000	181 000	6 769 000	6 580 000
Total Equity and Debt	41 366 000	52 861 000	46 976 000	43 744 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	344 000	853 000	883 000	796 000
Other Income	0	0	0	0
Revenue	344 000	853 000	883 000	796 000
Cost of Goods Sold	34 000	648 000	491 000	249 000
Salary Costs	0	0	0	0
Depreciation	115 000	224 000	219 000	219 000
Impairment	0	0	0	0
Expenditure	389 000	1 097 000	940 000	700 000
Operating Profit	−45 000	−245 000	−57 000	96 000
Financial Income	933 000	17 404 000	9 645 000	19 828 000
Financial Costs	2 271 000	706 000	560 000	1 201 000
Financial Balance	−1 338 000	16 698 000	9 085 000	18 627 000
Dividends	0	16 000 000	6 000 000	12 000 000
Net Income	−1 386 000	16 473 000	9 043 000	18 730 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	43 000	47 000	29 000	13 000
Real Eastate	472 000	472 000	472 000	472 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	226 000	341 000	465 000	684 000
Total Tangible Assets	698 000	813 000	937 000	1 156 000
Total Fiancial Fixed Assets	26 699 000	26 898 000	25 575 000	25 394 000
Total Fixed Assets	27 441 000	27 758 000	26 541 000	26 564 000
Stock	538 000	0	0	270 000
Total Investments	7 823 000	9 322 000	5 852 000	3 762 000
Cash, Bank	4 517 000	13 821 000	6 442 000	4 747 000
Total Current Assets	13 925 000	25 102 000	20 435 000	17 180 000
Total Assets	41 366 000	52 861 000	46 976 000	43 744 000
Total Equity	31 327 000	42 680 000	32 207 000	29 164 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	10 000 000	10 000 000	8 000 000	8 000 000
Creditors	9 000	11 000	2 000	20 000
Unpaid Taxes	31 000	164 000	208 000	0
Dividends	0	16 000 000	6 000 000	12 000 000
Other Current Debt	0	6 000	560 000	560 000
Total Current Debt	40 000	181 000	6 769 000	6 580 000
Total Equity and Debt	41 366 000	52 861 000	46 976 000	43 744 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−4,42 %	38,6 %	28,08 %	64,22 %
Debt-to-Equity Ratio	0,32	0,23	0,25	0,27
Operating Profit Margin	−13,08 %	−28,72 %	−6,46 %	12,06 %
Current Ratio	348,13	138,69	3,02	2,61
Quick Ratio	−27,96	138,69	3,02	2,72
Equity Ratio	0,76	0,81	0,69	0,67
Gross Profit Margin	90,12 %	24,03 %	44,39 %	68,72 %